Nuclear receptor PXR: discovery of a pharmaceutical anti-target.

Transcriptional induction of the gene encoding cytochrome P450 3A oxygenase (CYP3A) causes a prominent class of dangerous drug-drug interactions wherein one drug accelerates the metabolism of another. In our 1998 JCI paper, we reported the cloning of the human nuclear receptor PXR and demonstrated that it mediates CYP3A induction. We determined that PXR is expressed in liver, acts through a DNA response element located in the CYP3A promoter, and is activated by a structurally diverse collection of drugs that induce CYP3A. Our findings revealed the molecular basis for the CYP3A induction class of drug-drug interactions and provided a high-throughput means for screening out drug candidates with this activity.

[1]  Catatoxic steroids. , 1977, Advances in steroid biochemistry and pharmacology.

[2]  M. Yano,et al.  Regulation of cytochrome P450 genes: molecular mechanisms. , 1993, Pharmacogenetics.

[3]  R Ohlsson,et al.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[5]  W. Sabbagh,et al.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.

[6]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[7]  J. Lehmann,et al.  Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.

[8]  B. Neuschwander‐Tetri,et al.  Humanized xenobiotic response in mice expressing nuclear receptor SXR , 2000, Nature.

[9]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[10]  P. Guzelian,et al.  Cyp3A regulation: from pharmacology to nuclear receptors. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[11]  M. Redinbo,et al.  Structure and function of the human nuclear xenobiotic receptor PXR. , 2005, Current drug metabolism.

[12]  J. Staudinger,et al.  Pregnane X receptor and natural products: beyond drug–drug interactions , 2006, Expert opinion on drug metabolism & toxicology.